Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme

EuroIntervention

Volumn 7, Issue 3, 2011, Pages 314-322

  Lee, Michael S ^a   Yang, Tae ^a   Lasala, John M ^b   Cox, David A ^c   Bowman, Thomas S ^d   Starzyk, Ruth M ^d   Dawkins, Keith D ^d  

^a UCLA MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LEHIGH VALLEY HOSPITAL   (United States)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Coronary disease; In stent restenosis; Paclitaxel eluting stent; Percutaneous coronary intervention; Registries

Indexed keywords

PACLITAXEL;

ARTICLE; BARE METAL STENT; BRACHYTHERAPY; COMORBIDITY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; EVENT FREE SURVIVAL; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK FACTOR; SAFETY; STENT THROMBOSIS; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, LASER-ASSISTED; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; THROMBOSIS; TREATMENT OUTCOME;

EID: 80355141627     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I3A55     Document Type: Article

References (45)

1. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-36. (Pubitemid 27486458)
2. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-8. (Pubitemid 29511140)
3. Hoffmann R, Mintz GS. Coronary instent restenosis - predic- tors, treatment and prevention. Eur Heart J. 2000;21:1739-49.
4. Moscucci M, Piana RN, Kuntz RE, Kugelmass AD, Carrozza JP, Jr., Senerchia C, Baim DS. Effect of prior coronary restenosis on the risk of subsequent restenosis after stent placement or directional atherectomy. Am J Cardiol. 1994;73:1147-53. (Pubitemid 24184385)
5. Savage MP, Fischman DL, Schatz RA, Teirstein PS, Leon MB, Baim D, Ellis SG, Topol EJ, Hirshfeld JW, Cleman MW, Buchbinder M, Bailey S, Heuser R, Walker CM, Curry Jr RC, Gebhardt S, Rake R, Goldberg S. Long-term angiographic and clinical outcome after implanta- tion of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol. 1994;24:1207-12. (Pubitemid 24331857)
6. Mittal S, Weiss DL, Hirshfeld JW, Jr., Kolansky DM, Herrmann HC. Comparison of outcome after stenting for de novo versus restenotic narrowings in native coronary arteries. Am J Cardiol. 1997;80:711-5. (Pubitemid 27413577)
7. Walters DL, Harding SA, Walsh CR, Wong P, Pomerantsev E, Jang IK. Acute coronary syndrome is a common clinical presentation of instent restenosis. Am J Cardiol. 2002;89:491-4. (Pubitemid 34178555)
8. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260-4. (Pubitemid 43866610)
9. Habara S, Mitsudo K, Goto T, Kadota K, Fujii S, Yamamoto H, Kato H, Takenaka S, Fuku Y, Hosogi S, Hirono A, Yamamoto K, Tanaka H, Hasegawa D, Nakamura Y, Tasaka H, Otsuru S, Okamoto Y, Yamada C, Miyamoto M, Inoue K. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis. Heart. 2008;94:1162-5.
10. Mehran R, Dangas G, Abizaid A, Lansky AJ, Mintz GS, Pichard AD, Satler LF, Kent KM, Waksman R, Stone GW, Leon MB. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stent- ing: Short- and long-term results. Am Heart J. 2001;141: 610-4. (Pubitemid 32260729)
11. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, Lopez-Minguez JR, Angel J, Auge JM, Gomez-Recio M, Moris C, Seabra-Gomes R, Perez-Vizcayno MJ, Macaya C. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol. 2003;42:796-805. (Pubitemid 37059735)
12. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recur- rence of restenosis after stenting. N Engl J Med. 2001;344:250-6. (Pubitemid 32108529)
13. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treat- ment of in-stent restenosis. Circulation. 2002;106:1090-6. (Pubitemid 34970849)
14. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002;359:551-7. (Pubitemid 34178435)
15. Costa MA, Sabate M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, Serrano P, Coen VL, Levendag PC, Serruys PW. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999;100:789-92. (Pubitemid 29398874)
16. Baierl V, Baumgartner S, Pollinger B, Leibig M, Rieber J, Konig A, Krotz F, Sohn HY, Siebert U, Haimerl W, Duhmke E, Theisen K, Klauss V, Schiele TM. Three-year clinical follow-up after strontium-90/yttrium-90 beta-irradiation for the treatment of in-stent coronary restenosis. Am J Cardiol. 2005;96:1399-403. (Pubitemid 41566621)
17. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23. (Pubitemid 37186209)
18. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31. (Pubitemid 38067635)
19. Serruys PW, Ong ATL, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Otto-Terlouw PC. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention. 2005;1:58-65.
20. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Munzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double- blind, multicenter study of the Endeavor zotarolimus-eluting phos- phorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006;114:798-806. (Pubitemid 44268230)
21. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angio- plasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165-71. (Pubitemid 40095867)
22. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez-Minguez JR, Angel J, Mantilla R, Moris C, Cequier A, Sabate M, Escaned J, Moreno R, Banuelos C, Suarez A, Macaya C. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol. 2006;47:2152-60. (Pubitemid 43795079)
23. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295:1253-63.
24. Holmes DR, Jr., Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295:1264-73.
25. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW. Two-year clinical outcomes after paclitaxel-eluting stent or brachy- therapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008;29:1625-34. (Pubitemid 351958446)
26. Holmes DR, Jr., Teirstein PS, Satler L, Sketch MH, Jr., Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv. 2008;1:439-48.
27. Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS. Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheter Cardiovasc Interv. 2008;72:433-45.
28. Lasala JM, Cox DA, Lewis SL, Tadros PN, Haas RC, Schweiger MJ, Chhabra A, Untereker WJ, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS. Expanded use of the TAXUS Express stent: 2-year insights on safety from the 7500-patient ARRIVE registry program. EuroIntervention. 2009;5:67-77.
29. Abizaid A, Chan C, Lim YT, Kaul U, Sinha N, Patel T, Tan HC, Lopez-Cuellar J, Gaxiola E, Ramesh S, Rodriguez A, Russell ME. Twelve-month outcomes with a paclitaxel-eluting stent transition- ing from controlled trials to clinical practice (the WISDOM Registry). Am J Cardiol. 2006;98:1028-32. (Pubitemid 44486137)
30. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coro- nary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51. (Pubitemid 46685903)
31. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis E, Rake R, Goldberg S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331: 496-501. (Pubitemid 24256752)
32. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mecha- nisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996;94:1247-54. (Pubitemid 26307249)
33. Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, Schuhlen H, Seyfarth M, Schmitt C, Blasini R, Neumann FJ, Schomig A. Restenosis after coronary placement of various stent types. Am J Cardiol. 2001;87:34-9. (Pubitemid 32013081)
34. Schuhlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schomig A. Restenosis detected by routine angio- graphic follow-up and late mortality after coronary stent placement. Am Heart J. 2004;147:317-22. (Pubitemid 38176833)
35. Rathore S, Terashima M, Katoh O, Matsuo H, Tanaka N, Kinoshita Y, Kimura M, Tuschikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention. 2009;5:349-54.
36. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008; 51:607-14. (Pubitemid 351193101)
37. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation. 2007;115:3181-8. (Pubitemid 47012232)
38. Alfonso F, Perez-Vizcayno MJ, Cruz A, Garcia J, Jimenez- Quevedo P, Escaned J, Hernandez R. Treatment of patients with in-stent restenosis. EuroIntervention. 2009;5 Suppl D:D70-8.
39. Singh IM, Filby SJ, Sakr FE, Gorodeski EZ, Lincoff AM, Ellis SG, Shishehbor MH. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis. Cathet Cardiovasc Intervent. 2010;76:257-262.
40. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter ver- sus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-94.
41. Toutouzas K, Patsa C, Tsiamis E, Tsioufis C, Spanos A, Stefanadi E, Tentolouris C, Stefanadis C. Everolimus- and zotaroli- museluting stents for bare metal stent in-stent restenosis treatment: a prospective study. J Interv Cardiol. 2008;21:388-94.
42. Liistro F, Fineschi M, Grotti S, Angioli P, Carrera A, Ducci K, Gori T, Falsini G, Pierli C, Bolognese L. Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. J Am Coll Cardiol. 2010;55:613-6.
43. Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Smith H, Edmunds J, Varanasi J, Simonton CA, Group S. Outcomes and compli- cations with off-label use of drug-eluting stents. Results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. J Am Coll Cardiol Interv. 2008;1:405-14.
44. Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers E, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SM, Dawkins KDD, Baim DS. Drug-eluting stent thrombosis in routine clinical practice: 2 year outcomes and predictors from the TAXUS ARRIVE registries. Circ Cardiovasc Intervent. 2009;2:285-93.
45. Kushner FG, Hand M, Smith SC, Jr, King SB, III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:2271-306.